Overall, apocarotenoids showed potential protective effects in MS through modulating XBP‐1 spliced variant (XBP‐1/s), BiP, PERK, CHOP, and Syncytin‐1 in spinal cord. Here, XBP1 is linked to myeloid sarcoma.